Pterostilbene, silybin, and nicotinamide riboside supplement for exercise-related oxidative stress

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, triple-blind, placebo-controlled crossover trial will enroll 14 healthy male amateur runners aged 18–50. Participants will take either the ccPT-SIL-NR supplement or placebo twice daily for 14 days, perform a treadmill session at 80% VO2max, and provide blood and urine samples before and after exercise. After a washout period they will switch treatments and repeat the protocol, with the primary outcome being the change in plasma malondialdehyde (MDA). Secondary outcomes include urinary 8-OHdG and F2-isoprostanes, antioxidant enzyme activities, inflammatory and muscle-damage markers, cortisol, creatinine, and transcriptomic profiling.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male participants between 18 and 50 years of age who are amateur runners.
* Engage in at least 3 continuous running sessions per week, each lasting 60 minutes, which corresponds to a high level of physical activity according to the International Physical Activity Questionnaire (IPAQ).\*
* Self-report being able to continuously run for 45 minutes at high intensity without difficulty.
* Provide signed informed consent prior to participation in the study.
* Able to read, write, and speak either Catalan or Spanish.

  * High level of physical activity according to the IPAQ: vigorous physical activity (such as running) on at least 3 days per week, with a total energy expenditure ≥1500 MET-min/week.

MET value for vigorous activity = 8 × minutes × days per week.

Exclusion Criteria:

* Body Mass Index (BMI) ≤ 18 kg/m² or ≥ 30 kg/m².
* Presence of chronic diseases associated with increased oxidative stress, such as diabetes, hypertension, chronic obstructive pulmonary disease (COPD), or neurodegenerative diseases.
* Personal history of cardiovascular disease, including myocardial infarction, angina pectoris, stroke, or peripheral artery disease.
* Use of antibiotics within 30 days prior to study entry.
* Use of medications or vitamin supplements that may interfere with the study supplement and exceed 100% of the recommended daily intake within 30 days prior to the start of the study.
* Use of polyphenol supplements, herbal extracts, or phytotherapeutic products that may interfere with the study treatment within 30 days prior to study start.
* Alcohol consumption of 4 or more Standard Drink Units (SDUs) per day or 28 SDUs per week.\*

  \*One SDU is defined as 10 grams of alcohol. This corresponds approximately to: 1 glass of wine (120 mL), 1 beer (330 mL), or 1 small spirit (25 mL); 2 SDUs correspond to 1 glass of brandy or liqueur (55 mL), 1 whiskey (70 mL), or a mixed drink (75 mL).
* Active smoker.
* Unintentional weight loss of more than 3 kg in the past 3 months.
* Known food allergies and/or intolerances related to the study products.
* Presence of anemia.
* Presence of chronic gastrointestinal diseases\* or cancer.\*\*

  \*Chronic gastrointestinal diseases include those in an active phase that may interfere with nutrient absorption. Common examples include gastritis, hiatal hernia, Crohn's disease, celiac disease, irritable bowel syndrome, diverticulitis, diverticulosis, chronic constipation, and ulcerative colitis.

  \*\*Individuals with a history of cancer may be included only if they are in complete remission at the start of the study.
* Participation in another drug clinical trial or nutritional intervention study within 30 days prior to study inclusion.
* Inability to follow the study guidelines.

Where it's running

• Fundació Eurecat
  Reus, Tarragona, Spain Recruiting

Study contacts

• Principal investigator: Antoni Caimari, PhD — Fundació Eurecat
• Study coordinator: Antoni Caimari, PhD
• Email: antoni.caimari@eurecat.org
• Phone: +34 977 300 431

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers

  This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.

  Recruiting Neuromed IRCCS · Pozzilli · NCT07928453

• Opioid-Free vs Opioid-Based Anesthesia for Thyroid Surgery

  This study tests whether a non-opioid anesthesia approach can match or improve outcomes for adults undergoing thyroidectomy.

  Recruiting Malatya Egitim Ve Arastirma Hastanesi · Malatya · NCT07864155

• Training to reduce oxidative stress in knee OA

  A six-week program compares supervised knee-strengthening training with a daily 6,000-step walking plan to see if it improves pain, function, and blood markers of cellular stress in people with knee osteoarthritis.

  Recruiting Vrije Universiteit Brussel · Capelle aan den IJssel · NCT07845838

• Ashwagandha with resistance training to boost strength and stress markers

  This 12-week study tests whether taking ASHWAGANDHA along with regular resistance training helps healthy, trained men see improvements in strength, stress levels, sleep, and cognitive function compared with a placebo.

  Recruiting Gdansk University of Physical Education and Sport · Gdansk, Pomeranian Voivodeship · NCT07803068

• Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis

  This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.

  Recruiting University of La Laguna · Santa Cruz de Tenerife, Canary Islands · NCT07760662

• NVTIA Ergothioneine for Healthy Aging and Skin Health

  This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.

  Recruiting European Life Science Research Association · Dhaka · NCT07750002

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.